Founder Directory
Global company intelligence with up to 500 companies per country, mapped by Tier 1, Tier 2, and Tier 3 markets.
Pillar Hubs
Jump to country, industry, stage, startup taxonomy, and newsroom hubs connected to founder discovery.
Trending Founders
18 records
NNewLimit
Developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare
Last round: Series B Founders Fund, $130M Series B in 2025
RTROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals
Last round: Series B Andreessen Horowitz, $50M Series B in 2021, $70M valuation
HFHoxton Farms
Grow real animal fat without the animals for delicious, cruelty-free, sustainable ingredient Biotech Sustainability
Last round: Series A Founders Fund, $22M Series A in 2022
KKernel
Kernel is a neuroscience company that specializes in developing brain-recording technologies. Biotech Life Science
Last round: Series C Khosla Ventures, $153M Series C in 2020
SSynchron
Restore lives by deciphering the neural code of the brain Biotech Healthcare Hardware
Last round: Series C Khosla Ventures, $75M Series C in 2022
CLClear Labs
Clear Labs is a provider of a fully-automated sequencing platform for turnkey diagnostics. Biotech Healthcare Robotics Hardware
Last round: Series C Khosla Ventures, $58M Series C in 2020
BLBioAge Labs
BIOAGE targets aging to develop drugs that treat severe diseases Biotech
Last round: Series D Andreessen Horowitz, $170M Series D in 2024
KKarius
Karius provides genomic insights for infectious diseases to enable clinicians to make life-saving treatment decisions. Biotech Genetics Healthcare
Last round: Series B Khosla Ventures, $165M Series B in 2020
CTCAMP4 Therapeutics
BioTech. Solving how genes are controlled to drive the efficient development of treatments. Biotech
Last round: Series B Andreessen Horowitz, $100M Series B in 2022
PTPendulum Therapeutics
Pendulum Therapeutics improves health through products targeting the microbiome. Biotech Healthcare
Last round: Series C Sequoia, Khosla Ventures, $54M Series C in 2021
MMirvie
Creates precise, actionable, and non-invasive tests for maternal-fetal health Biotech Healthcare
Last round: Series B Khosla Ventures, $45M Series B in 2022, $155M valuation
LLoyal
We're developing medicines that help dogs live healthier, longer. Biotech Pets Healthcare
Last round: Series A Khosla Ventures, $27M Series A in 2021
TTeckro
Teckro is a life science technology company that is rethinking every element of clinical research. Biotech Healthcare Clinical Research
Last round: Series C Founders Fund, $25M Series C in 2021
ZMZeit Medical
Building devices and software to provide brain health monitoring for neurology injury patients Biotech Healthcare Medical Device
Last round: Seed Y Combinator, $2M Seed in 2021
Elemental Machines
Smart lab platform delivers powerful, data-driven insights that improve R&D, laboratory operations, and manufacturing outcomes. Biotech SaaS
Last round: Series A Founders Fund, $2M Series A in 2020
HLHound Labs
Hound Labs develops ultra-sensitive technology for non-invasive breath measurement. Biotech Cannabis Testing
Last round: Series D Benchmark, $20M Series D in 2021
CGCofactor Genomics
Experimental Design, Next-generation sequencing, Advanced Analysis and Visualization Biotech Healthcare Clinical Trials Diagnostics
Last round: Series A Y Combinator, $7M Series A in 2021
ILIndee Labs
Indee Labs is unlocking gene-modified cell therapy for the masses with scalable hardware for gene delivery. Biotech Hardware
Last round: Growth Founders Fund, Y Combinator, Raised $3M in 2021